|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
3.940 +0.060 (+1.546%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 187,137 | -18.890% | 470,833 | 491,373 | 406,461 | 415,862 |
| Cost of Sales | (49,149) | 0.386% | (103,087) | (102,168) | (92,463) | (91,518) |
| Gross Profit | 137,988 | -24.082% | 367,746 | 389,205 | 313,998 | 324,344 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,238 | 62.042% | (21,441) | 2,210 | (21,972) | (3,185) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,265) | 253.354% | (4,154) | (12,381) | (13,943) | (11,711) | |
| Profit / (Loss) before Taxation | (138,564) | -35.123% | (740,713) | (735,340) | (1,156,344) | (377,555) | |
| Taxation | 3,792 | -20.269% | 23,340 | 6,284 | 34,302 | 6,161 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 3,066 | 25,302 | 64,343 | (2,242) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (134,772) | -34.731% | (714,307) | (703,754) | (1,057,699) | (373,636) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,172 | -26.854% | 6,297 | 28,259 | 9,975 | (47,575) |
| Depreciation & Amortisation | 49,368 | -15.596% | 111,109 | 124,787 | 112,352 | 51,621 |
| Directors' Emoluments | -- | -- | 7,376 | 3,905 | 4,539 | 4,478 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -31.000 | -34.043% | -163.000 | -161.000 | -242.000 | -85.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.054 | (1.393) | (1.666) | (1.042) |
| NBV per share ($) | 4.685 | -- | 5.014 | 6.623 | 8.181 | 10.307 |
| Remarks: | Real time quote last updated: 11/09/2025 17:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -134,772 |
| %Change | -34.731% |
| EPS / (LPS) | RMB -0.310 |
| NBV Per Share (¥) | RMB 4.685 |